πŸ‡ΊπŸ‡Έ FDA
Patent

US 7481212

Increased dosage metered dose inhaler

granted A61PA61P43/00

Quick answer

US patent 7481212 (Increased dosage metered dose inhaler) held by Nektar Therapeutics expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61P, A61P43/00